Cancer Drug Discovery Group (CDDG)
The latest figures from The Cancer Institute NSW indicate that the risk of being diagnosed with cancer is now one in two for males and one in three for females up to the age of 85 years. In 2006, more than 13,000 people died from cancer in NSW.
Overarching aims of the Cancer Drug Discovery Group are to improve our understanding of the biological processes underlying cancer, develop improved methods of detection and treatment for cancer, and apply what is known in the areas of cancer screening and cancer prevention.
The CDDG encompasses multi-disciplinary grouping of researchers based at the University of Wollongong, Wollongong Hospital and private cancer clinics using drug design, synthetic organic/medicinal chemistry, radio-imaging, tumour cell biology, and preclinical assessment to identify and validate new and/or improved classes of chemotherapeutics and diagnostics for cancer.